Optogenetic therapy, based on Nobel prize-winning science, involves turning nerve cells on and off using light
A type of gene therapy based on Nobel prize-winning science is safe and can partly restore sight in blind people, researchers have revealed.
The approach, known as optogenetic therapy, harnesses the technique for turning nerve cells on and off using light that scooped the 2026 Nobel prize in physiology or medicine.
